The inherent challenge in modeling three-dimensional molecular conformations stems from the intricacies of spatial orientation and chemical bonding, elements not naturally or efficiently captured by sequence-based models. Existing approaches have often relied on graph or voxel representations, which, while informative, do not lend themselves well to the sequential learning frameworks that have powered recent AI breakthroughs. ConfSeq circumvents this barrier by encoding molecules in a sequence format that is both invariant to transformations in three-dimensional space—such as rotation and translation—and compact enough to facilitate scalable learning. This design opens the door for applying sophisticated transformer architectures, the backbone of many state-of-the-art language models, to a domain previously considered incompatible.

Transformers flourish in handling sequences, extracting nuanced patterns, and learning contextual relationships by design. However, applying these architectures to 3D molecular data necessitates a linguistically coherent encoding of molecular conformations. ConfSeq ingeniously fulfills this requisite by reprising SMILES’ linear notation and embedding additional geometric descriptors within the sequence. The inclusion of dihedral and bond angles enables the explicit capture of rotational and angular molecular features, while the pseudo-chirality descriptor encodes stereochemical nuances often critical to biological activity and pharmaceutical efficacy. This blend ensures that the molecular representation retains chemical fidelity crucial for downstream modeling tasks, from property prediction to generative design.

Perhaps most compelling is how ConfSeq repurposes core three-dimensional molecular modeling challenges—long considered discrete and computationally intensive—into sequence modeling problems amenable to machine learning frameworks optimized for text and language. Tasks such as predicting molecular conformations, de novo design of novel compounds, and constructing rich molecular embeddings for representation learning are redefined under this paradigm. With ConfSeq, these traditionally disparate objectives converge on a single computational frontier, exploiting transformers’ unparalleled capability to learn from sequences. This harmonization leads to marked performance gains across diverse benchmarks, asserting the method’s superiority over existing modalities.

The practical implications of ConfSeq’s establishment are vividly illustrated in its contribution to drug discovery, a field demanding precise knowledge of molecular geometry for effective design. Utilizing ConfSeq-enabled platforms, the researchers successfully identified multiple novel inhibitors of the stimulator of interferon genes (STING) pathway, a crucial target in immunotherapy, alongside inhibitors of ALDH1B1, implicated in various metabolic pathways and potential oncogenic processes. The lead compounds demonstrated half-maximal inhibitory concentrations (IC50) impressively ranging between 0.338 and 3.51 micromolar, signaling potent bioactivity. Such performance not only validates the method’s practical utility but also underscores its potential to accelerate the drug discovery pipeline by harnessing the generative and predictive prowess of advanced language models.

This integration between three-dimensional structural biology and language model technology reflects an emergent trend where conventional chemical informatics tools are augmented by AI constructs originally designed for linguistic processing. It exemplifies a multidisciplinary fusion that leverages the precision of chemical descriptors and the expansive learning capacity of machine learning. The conceptual leap underlying ConfSeq addresses a pivotal question in cheminformatics: how to translate rich spatial information into a data structure that preserved essential chemical properties yet could be digested by sequence-based AI architectures.

One of the most striking aspects of ConfSeq lies in its commitment to SE(3) invariance—the mathematical property ensuring that molecular representations remain unchanged under spatial transformations including rotations and translations. By constructing the internal coordinates carefully, the language maintains this invariance, which is essential for consistent modeling of molecules regardless of how they are oriented in space. This is no minor feat, as three-dimensional rotational invariance frequently challenges machine learning methods applied to molecular data. Preserving this attribute ensures that models trained on ConfSeq data develop genuine chemical intuition and robustness rather than memorizing artifacts from arbitrary orientations.

The modular design of ConfSeq also encourages extensibility and human interpretability, maintaining the simplicity characteristic of SMILES strings while enriching them with geometric dimensions. This positions the language not just as a tool for AI, but as a bridge facilitating enhanced understanding and communication between chemists, biologists, and computational scientists. Its readable token sequences democratize the representation of molecular conformations, enabling the use of standard NLP tools, which had been impossible with unstructured three-dimensional data formats.

Crucially, ConfSeq’s development signals a broader shift toward standardizing conformation-aware molecular languages, paving the way for more generalizable AI models capable of understanding molecular structures deeply. Prior attempts at molecular language design often sacrificed either spatial fidelity or sequence compatibility. ConfSeq reconciles these competing demands through a harmonious fusion of domain knowledge and machine learning principles, exemplifying a new generation of interdisciplinary methodologies.

Beyond drug discovery, the implications of ConfSeq extend to materials science, catalysis research, and structural biology. Its framework potentially enables the synthesis of novel materials with bespoke properties by facilitating AI-driven exploration of the vast conformational space that defines molecular functionality. Similarly, enzyme modeling and protein-ligand interactions may benefit from this sequence-centric methodology, offering insights into complex biochemical phenomena with greater efficiency.

Additionally, the confounding problem of stereochemistry representation in AI has long been a bottleneck due to its subtle but critical role in molecular behavior. The pseudo-chirality descriptor embedded within ConfSeq offers a novel solution by capturing stereochemical information within a discrete token framework. This advancement allows AI models to discern and predict chiral-dependent activities and interactions, an indispensable capability for realistic molecular simulations and rational design.

In the context of transformer architectures, the alignment with ConfSeq notably enhances performance by providing well-structured input sequences rich in chemical context and spatial awareness. This pairing leverages transformers’ depth of attention mechanisms and parallel processing capabilities to model complex, non-linear relationships that underpin molecular shape and function. The resulting models are not only powerful in prediction but also possess generative capacity, enabling the proposal of previously uncharacterized molecules with targeted properties.

The success of ConfSeq underscores the transformative potential of rethinking molecular data representation through the lens of artificial intelligence. By embedding detailed three-dimensional information into a language that mirrors the structure and familiarity of natural language processing vocabularies, a new frontier of molecular AI has been opened. This paradigm shift promises to expedite discoveries that depend on nuanced understanding of molecular geometries and their biological or chemical consequences.

Looking forward, the widespread adoption of ConfSeq could standardize data sharing and model training protocols in the molecular sciences, fostering collaboration across academia, industry, and AI research. Its capability to merge detailed chemical descriptor fidelity with the computational efficiency of language models aligns perfectly with the growing trend of integrating AI into experimental pipelines to forecast outcomes, reduce failure rates, and discover novel entities with reduced time and cost.

In summary, ConfSeq represents a profound leap in modeling molecular conformations by recasting three-dimensional structures into a tokenized language compatible with the latest in artificial intelligence. Bridging the divide between molecular geometry and sequential data modeling, it empowers state-of-the-art transformer architectures to approach longstanding problems in molecular science with unprecedented precision and generativity. This innovation heralds a new era where AI not only comprehends but designs molecules in full three-dimensional detail, offering promising horizons for drug discovery and beyond.

Subject of Research: Artificial intelligence application in three-dimensional molecular modeling; molecular conformation representation; integration of language models with chemical informatics.

Article Title: Bridging three-dimensional molecular structures and artificial intelligence with a conformation description language.

Article References:
Xiong, J., Shi, Y., Wu, M. et al. Bridging three-dimensional molecular structures and artificial intelligence with a conformation description language. Nat Mach Intell (2026). https://doi.org/10.1038/s42256-026-01250-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s42256-026-01250-8

Proteins, fundamental biomolecules that govern life itself, are being decoded with unprecedented accuracy. The advent of sophisticated models capable of predicting protein structures has dismantled long-standing barriers in structural biology. Beyond predicting static structures, these models offer insights into dynamic conformational changes and functional annotations, illuminating pathways previously shrouded in complexity. This represents not just an incremental advance but a paradigm shift, as the conventional methods of experimental elucidation are complemented and, in some cases, superseded by computational foresight.

In parallel, the interpretation of genomic regulation is undergoing a renaissance driven by deep learning. Molecular biology’s age-old enigma—how the genome’s regulatory elements precisely control gene expression—finds new clarity through models that can digest single-cell expression profiles and chromatin accessibility data. By reconstructing the multilayered regulatory networks, these models enable a more holistic understanding of cellular behavior and disease states, opening avenues for targeted therapeutics and personalized medicine that leverage a patient’s unique molecular signature.

Perhaps most striking is the revolution in de novo molecular design and synthesis planning, which is redefining medicinal chemistry and materials science. Large language models (LLMs) harness chemical languages such as SMILES strings, empowering researchers to invent novel molecules with desired properties while simultaneously charting feasible synthetic routes. This synergy not only accelerates the traditionally lengthy and costly drug discovery pipelines but also pushes the boundaries of creativity in molecular innovation, contributing to sustainable chemistry and efficient material development.

Such advancements signify an overarching trend toward unified, multimodal frameworks that reconcile diverse datasets into integrated foundation models. These architectures do not simply operate in silos of protein sequences or chemical structures but instead amalgamate heterogeneous data types—genomic, transcriptomic, proteomic, and chemical information—yielding comprehensive representations that imbue models with robustness and versatility. This integration signals a new era where biological and chemical phenomena are decoded through a shared computational prism.

Yet, this burgeoning field grapples with critical challenges. Central among them is the alignment of model capabilities with established biological and chemical knowledge. The mere ability to ingest large datasets is insufficient; the learning process necessitates embedding fundamental domain insights as priors—guiding the models to respect the axioms and constraints inherent in natural systems. This convergence of empirical knowledge and computational prowess is essential to ensure both scientific rigor and practical utility.

Complementing this is the vital need for standardized benchmarks that enable rigorous model evaluation. Without universally accepted metrics and datasets, comparing model performance becomes an exercise fraught with inconsistency, stymieing progress and reproducibility. Such benchmarks are crucial not only for validating predictions but also for facilitating iterative improvements, fostering an environment of transparent innovation in the bio/chemical machine learning community.

Concurrently, interpretability remains a frontier challenge. While LLMs exhibit remarkable predictive and generative capabilities, understanding the rationale behind their outputs is imperative for building trust among biologists and chemists. Deciphering the decision-making processes within these models will bridge the gap between computational predictions and experimental validation, nurturing confidence and accelerating adoption in practical settings.

Looking forward, the trajectory of bio/chemical LLMs is oriented toward more interactive, agentic systems—intelligent assistants endowed with the ability to participate actively in hypothesis generation and experimental design. These agents will not only process input data but engage cognitively with scientists, suggesting experiments, identifying anomalies, and even driving discovery cycles autonomously. Such developments promise to revolutionize the design–build–test–learn paradigm, compressing timelines and amplifying scientific creativity.

The implications of these advancements ripple across multiple sectors. In pharmaceuticals, accelerated drug discovery could bring novel therapeutics to market faster, addressing unmet medical needs with precision-tailored molecules. In agriculture, improved understanding of plant regulatory networks may lead to resilient crops adapted to changing climates. Environmental science stands to benefit through novel catalysts and materials designed to remediate pollution or optimize renewable energy technologies—all underpinned by these versatile computational frameworks.

Nevertheless, this brave new world demands sustained interdisciplinary collaboration. Harnessing the full potential of bio/chemical LLMs requires chemists, biologists, data scientists, and AI specialists to converge, exchanging insights and forging protocols that balance innovation with safety and ethical considerations. This collective intelligence will be paramount in steering the field away from pitfalls and towards responsible, impactful applications.

Moreover, the field must remain vigilant about data quality and representation biases. The heterogeneity and noise inherent in biological and chemical datasets pose risks of skewed learning and misleading predictions. Proactive strategies, such as curating diverse and representative datasets alongside robust validation techniques, are indispensable pillars supporting the integrity of these transformative models.

Beyond immediate applications, these technological strides hint at a profound reconceptualization of molecular sciences. The very notion of molecules as “languages” redefines how scientists think about chemical and biological information. This linguistic metaphor offers a conceptual framework that unifies disparate realms—from nucleotide sequences to synthetic polymers—under a comprehensive computational umbrella, fostering a holistic understanding of life and matter.

Ultimately, the rise of large language models in biology and chemistry embodies a fusion of human ingenuity and machine intelligence. As these models mature into foundational platforms, they promise to accelerate discovery cycles, inform experimental strategies, and inspire innovations beyond current imagination. The future of molecular science is not merely one of accumulation but of integration and synthesis—where data, knowledge, and computational creativity converge to unlock the secrets of life and matter at unprecedented scales and depths.

Subject of Research: The integration of large language models in biology and chemistry for molecular representation, prediction, and design.

Article Title: A survey on large language models in biology and chemistry.

Article References:
Ashyrmamatov, I., Gwak, S.J., Jin, S.Y. et al. A survey on large language models in biology and chemistry. Exp Mol Med (2026). https://doi.org/10.1038/s12276-025-01583-1

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s12276-025-01583-1